Dutasteride 0.5 mg

DRUG6 trials

Sponsors

GlaxoSmithKline, Yuyu Pharma, Inc., Pellficure Pharmaceuticals, Inc, Corpometria Institute, Ain Shams University

Conditions

AlopeciaBenign Prostatic HyperplasiaCategory IIIB Chronic ProstatitisCovid19DutasterideProstate CancerSalivary Duct Carcinoma

Phase 1

Pharmacokinetics and Safety/Tolerability of YY-201 in Comparison to Dutasteride and Tadalafil

CompletedNCT03240939

Yuyu Pharma, Inc.Benign Prostatic Hyperplasia

Start: 2017-03-27End: 2017-10-10Updated: 2017-11-24

Study of PCUR-101 in Combination With ADT in Patients With mCRPC

TerminatedNCT04677855

Pellficure Pharmaceuticals, IncProstate Cancer

Start: 2021-03-30End: 2023-11-20Updated: 2024-04-10

Phase 2

EAT-DUTA AndroCoV Trial

CompletedNCT04729491

Corpometria InstituteCovid19

Start: 2020-06-30End: 2020-10-07Updated: 2021-01-28

Role of Dutasteride in Treatment of Chronic Prostatitis

CompletedNCT04756206

Ain Shams UniversityCategory IIIB Chronic Prostatitis, Dutasteride

Start: 2019-01-01End: 2020-09-01Updated: 2021-02-16

Phase II Dutasteride in Combination With CAB vs CAB in SDC

RecruitingNCT05513365

Radboud University Medical CenterSalivary Duct Carcinoma

Start: 2022-09-27End: 2027-09-30Target: 26Updated: 2025-06-04

Phase 3

A Long-term Study to Determine Safety and Efficacy of Dutasteride in Male Subjects With Androgenetic Alopecia

CompletedNCT01831791

GlaxoSmithKlineAlopecia

Start: 2013-04-14End: 2014-07-19Updated: 2018-06-20

Related Papers

A randomized phase II trial on the addition of dutasteride to combined androgen blockade therapy versus combined androgen blockade therapy alone in patients with advanced or metastatic salivary duct carcinoma - the DUCT study protocol.

2024-09-204 citations

Short course of dutasteride in treatment of a refractory category IIIB chronic prostatitis (A placebo-controlled study)

Prostate International2022-06-206 citations

Long‐term safety and efficacy of dutasteride in the treatment of male patients with androgenetic alopecia

The Journal of Dermatology2016-02-1958 citations